KR101942771B1 - Separating composition for gastropoda - Google Patents
Separating composition for gastropoda Download PDFInfo
- Publication number
- KR101942771B1 KR101942771B1 KR1020150127009A KR20150127009A KR101942771B1 KR 101942771 B1 KR101942771 B1 KR 101942771B1 KR 1020150127009 A KR1020150127009 A KR 1020150127009A KR 20150127009 A KR20150127009 A KR 20150127009A KR 101942771 B1 KR101942771 B1 KR 101942771B1
- Authority
- KR
- South Korea
- Prior art keywords
- phosphate
- composition
- pyrophosphate
- sodium
- calcium pyrophosphate
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 241000237858 Gastropoda Species 0.000 title claims description 17
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract description 46
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims abstract description 23
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 18
- 239000010452 phosphate Substances 0.000 claims abstract description 18
- -1 phosphate compound Chemical class 0.000 claims abstract description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 27
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 claims description 25
- 229940043256 calcium pyrophosphate Drugs 0.000 claims description 25
- 235000019821 dicalcium diphosphate Nutrition 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 9
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 9
- 235000019800 disodium phosphate Nutrition 0.000 claims description 9
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 6
- 235000019797 dipotassium phosphate Nutrition 0.000 claims description 6
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 6
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 239000001736 Calcium glycerylphosphate Substances 0.000 claims description 3
- ZQKXOSJYJMDROL-UHFFFAOYSA-H aluminum;trisodium;diphosphate Chemical compound [Na+].[Na+].[Na+].[Al+3].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O ZQKXOSJYJMDROL-UHFFFAOYSA-H 0.000 claims description 3
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 claims description 3
- 229940095618 calcium glycerophosphate Drugs 0.000 claims description 3
- 235000019299 calcium glycerylphosphate Nutrition 0.000 claims description 3
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 3
- 239000011706 ferric diphosphate Substances 0.000 claims description 3
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 3
- 229910000398 iron phosphate Inorganic materials 0.000 claims description 3
- WBJZTOZJJYAKHQ-UHFFFAOYSA-K iron(3+) phosphate Chemical compound [Fe+3].[O-]P([O-])([O-])=O WBJZTOZJJYAKHQ-UHFFFAOYSA-K 0.000 claims description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 3
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 3
- 229960002901 sodium glycerophosphate Drugs 0.000 claims description 3
- REULQIKBNNDNDX-UHFFFAOYSA-M sodium;2,3-dihydroxypropyl hydrogen phosphate Chemical compound [Na+].OCC(O)COP(O)([O-])=O REULQIKBNNDNDX-UHFFFAOYSA-M 0.000 claims description 3
- GHHVYBBTKTVOPA-UHFFFAOYSA-K aluminum;sodium;phosphate Chemical compound [Na+].[Al+3].[O-]P([O-])([O-])=O GHHVYBBTKTVOPA-UHFFFAOYSA-K 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 239000001506 calcium phosphate Substances 0.000 claims 1
- 229910000389 calcium phosphate Inorganic materials 0.000 claims 1
- 229960001714 calcium phosphate Drugs 0.000 claims 1
- 235000011010 calcium phosphates Nutrition 0.000 claims 1
- XZTWHWHGBBCSMX-UHFFFAOYSA-J dimagnesium;phosphonato phosphate Chemical compound [Mg+2].[Mg+2].[O-]P([O-])(=O)OP([O-])([O-])=O XZTWHWHGBBCSMX-UHFFFAOYSA-J 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 229940083542 sodium Drugs 0.000 claims 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims 1
- 238000000926 separation method Methods 0.000 abstract description 23
- 239000003795 chemical substances by application Substances 0.000 abstract description 14
- 239000004480 active ingredient Substances 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 5
- 239000007788 liquid Substances 0.000 abstract description 4
- 230000000361 pesticidal effect Effects 0.000 abstract description 2
- 230000004083 survival effect Effects 0.000 description 9
- 150000007524 organic acids Chemical class 0.000 description 8
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 8
- 229940048086 sodium pyrophosphate Drugs 0.000 description 8
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 8
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 8
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 239000013535 sea water Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 229960004368 oxytetracycline hydrochloride Drugs 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000003599 detergent Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000254173 Coleoptera Species 0.000 description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 2
- 241000237852 Mollusca Species 0.000 description 2
- 239000004100 Oxytetracycline Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000012447 hatching Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229960000625 oxytetracycline Drugs 0.000 description 2
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 2
- 235000019366 oxytetracycline Nutrition 0.000 description 2
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 241000545744 Hirudinea Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 241000287127 Passeridae Species 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000036848 Porzana carolina Species 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 231100000693 bioaccumulation Toxicity 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000021403 cultural food Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004349 growth plate Anatomy 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229960003339 sodium phosphate Drugs 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 229940048102 triphosphoric acid Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
- C01B25/16—Oxyacids of phosphorus; Salts thereof
- C01B25/18—Phosphoric acid
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
- C01B25/16—Oxyacids of phosphorus; Salts thereof
- C01B25/26—Phosphates
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Environmental Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The present invention relates to a gastropathic separation agent composition, and more particularly, to a gastropathic separation composition comprising a phosphoric acid or a phosphate compound as an active ingredient. The pesticidal composition of the present invention is advantageous in that it is more excellent in separation effect than the conventional separating agent, is significantly reduced in mortality rate, is economical, can be provided in the form of a liquid, and thus is convenient for the user.
Description
The present invention relates to a gastropathic detergent composition capable of safely and efficiently separating gastropods in the process of culturing gastropods, which are a group of molluscs such as abalone, beetle, crab, crab, and ovary.
It is common to use shelltara tools in the process of producing gastropods such as abalone and sora. Abalone aquaculture is composed of bottom (broo, line), shelter, and food culture platelets. Abalone is screened four times at the stage of staining during the aquaculture process and several times in size and condition at the stage of success. Sheltered abalone plays a role as a growth plate that can survive after attaching at the stage of hatching after hatching.
Abalone has a habit of attaching to the shelter. Therefore, it is necessary to separate the gastropods before sorting. Three methods for overturning are widely used in the farms.
First, there are methods of separating abalone by individual labor force, secondly, separating abalone by spraying high-pressure seawater, and finally separating abalone from shell tar by treating special medicines. In the case of a method in which a person manually separates by hand, the mortality rate of overturning due to physical injury or stress is high due to separation by applying force, and the economical efficiency is low due to low separation efficiency compared with labor input.
Secondly, there is a method of separating the abalone by spraying water pressure. However, in this case as well as the first method, there is a possibility of causing physical injury.
Finally, there is a method of separating the abalone from the shelter by treating special medicines. This method is widely used because it is the easiest and most economical method.
Oxytetracycline hydrochloride is mainly used as an antibiotic agent, which is mainly used for separating abalone from the bottom of the shell or from the bottom. Oxytetracycline hydrochloride temporarily paralyzes the muscles of gastropods such as abalone to allow easy separation from shell tar. It is a substance that is mainly used because it has the effect of preventing disease.
However, excessive or long-term use of antibiotics such as oxytetracycline hydrochloride may cause persistence, bioaccumulation and destruction of surrounding ecosystems, which may lead to antibiotic resistance problems. In addition, when oxytetracycline hydrochloride is used, the possibility of death of about 10 to 15% of rollover staple is raised, and further, the antibiotic component remains in the gastrointestinal body and the antibiotic substance is detected at the time of examination, There is a problem that the merchantability is lowered by taking the period of abandonment of about 30 days or more.
In addition, though the organic acid is used to separate the abalone, the existing organic acid-based abalone separating agent has a low separation rate and a high survival rate. In particular, if the concentration of the organic acid is increased in order to increase the separation rate, the survival rate greatly decreases.
Therefore, it is very urgent to introduce a separating agent composition which can replace this.
As described above, when oxytetracycline is used as an antibiotic, it may cause death due to antibiotics, residual antibiotics, and destruction of surrounding ecosystem. Therefore, .
In addition, the existing organic acid-based rolled separating agent has a low separation rate and a high survival rate.
Accordingly, it is an object of the present invention to provide a detergent composition which is easy to separate gastropods without oxytetracycline hydrochloride or organic acid and has a remarkably low mortality.
SUMMARY OF THE INVENTION The present invention has been made to solve the above-mentioned problems of the prior art,
And a phosphate compound or a phosphate compound as an active ingredient.
In the present invention, the phosgene or phosphate compound is contained in an amount of 1 to 50 wt% based on the total weight of the composition.
Further, in the present invention, a composition for isolating gastropods further comprising propylene glycol.
In the present invention, the propylene glycol is contained in an amount of 1 to 40% by weight based on the total weight of the composition.
In the present invention, the phosphate compound may be at least one selected from the group consisting of iron phosphate, potassium phosphate monobasic, potassium phosphate dibasic, potassium phosphate dibasic, sodium phosphate dibasic, sodium phosphate dibasic, sodium phosphate dibasic, Calcium phosphate monobasic, calcium pyrophosphate, calcium pyrophosphate, calcium pyrophosphate, calcium pyrophosphate, calcium pyrophosphate, calcium pyrophosphate, calcium pyrophosphate, calcium pyrophosphate, calcium pyrophosphate, calcium pyrophosphate, calcium pyrophosphate, Wherein the composition is at least one selected from the group consisting of sodium phosphate, sodium glycerophosphate, calcium glycerophosphate, ferric pyrophosphate, iron pyrophosphate, sodium aluminum phosphate, and basic aluminum phosphate. .
Also, in the present invention, the composition is diluted with an excipient containing water such that the concentration of the phosphoric acid or the phosphate compound is 0.01 to 0.5% by weight.
In the present invention, the gastropod separation composition is characterized in that the gastropods are rolled over.
The pesticidal composition of the present invention is advantageous in that it is more excellent in separation effect than the conventional separating agent, is significantly reduced in mortality rate, is economical, can be provided in the form of a liquid, and thus is convenient for the user.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a photograph showing a process of spraying a separator composition produced in an embodiment of the present invention in a shelter having a rolled spatula attached thereto.
FIG. 2 is a photograph showing a process of spraying water after spraying the separator composition prepared in the embodiment of the present invention, and separating the overturned duster into a drainage port.
Hereinafter, the present invention will be described in detail.
The present invention relates to a gastropod separation composition comprising phosphoric acid or a phosphate compound as an active ingredient.
Here, the is, as a general term of phosphorus pentoxide P 2 O 5 is the sign language series of acid resulting from (水和) mP 2 O 5 · nH 2 O ( wherein m, n are each, independently a natural number referred to as "phosphate" ), Metaphosphoric acid, pyrophosphoric acid, olophosphoric acid, triphosphoric acid, sphinganic acid, and the like, and there may be a series of polymethaphosphoric acid produced by polymerization of metaphosphoric acid.
The "phosphate compound" refers to a salt formed by the phosphoric acid with another element, and includes both hydrogen phosphate (H 3 PO 4 ) and hydrogen phosphate (H 2 PO 4 ). Non-limiting examples of such phosphate compounds include iron phosphate, potassium phosphate monobasic, potassium phosphate dibasic, potassium phosphate dibasic, sodium phosphate dibasic, sodium phosphate dibasic, sodium phosphate dibasic, ammonium phosphate monobasic, Calcium pyrophosphate, sodium pyrophosphate, sodium pyrophosphate, sodium pyrophosphate, calcium pyrophosphate, calcium pyrophosphate, calcium pyrophosphate, sodium pyrophosphate, sodium pyrophosphate, sodium pyrophosphate, sodium pyrophosphate, sodium pyrophosphate , Sodium glycerophosphate, calcium glycerophosphate, ferric pyrophosphate, iron pyrophosphate, sodium aluminum phosphate, and basic aluminum sodium phosphate.
Conventional organic acid - based abalone isolate had low isolation and high survival rate after isolation. Particularly, when the concentration of the organic acid is increased in order to increase the separation rate, this phenomenon becomes more prominent.
Currently, citric acid, which is one of the most used organic acids, is sold as a fungicide for foot-and-mouth disease virus, which is a non-skin virus in livestock farms, and has high damage to protein membrane and strong disinfection ability.
However, in the case of phosphoric acid, phosphorus is one of the main constituents of the cell membrane of animal cells, and toxicity to spots such as abalone may be lower than that of other acids, and there is no fear of residues and hydrophilicity is high, It is easily washed without leaving, and has a high solubility in seawater.
The phosphoric acid or phosphate compound is preferably contained in an amount of 1 to 50% by weight, more preferably 5 to 30% by weight based on the weight of the entire composition. More details of this will be understood with reference to the following embodiments.
In the present invention, in addition to the phosphoric acid or phosphate compound, propylene glycol may further be contained. Propylene glycol is a substance which is used for the purpose of increasing the dispersing ability when it is diluted in seawater in the prevention of caking of winter products and also has an effect of reducing mortality which may be caused as a phosphoric acid or a phosphate compound, Or 30% by weight or more based on the total composition) than when the phosphate compound is low in concentration. More details of this will be understood with reference to the following embodiments.
The propylene glycol is preferably contained in an amount of 1 to 40% by weight based on the total weight of the composition. If it is less than 1% by weight, it may be insufficient for preventing the caking-up and for increasing the dispersibility of seawater, and the effect of lowering the mortality rate may be insufficient. If the amount is more than 40% by weight, There is a possibility of remaining in the later gastropods, and the degree of increase in the degree of the further improvement in the degree of hyperlipidemia or the mortality rate may be insignificant, which is also not economically advantageous.
In the present invention, the composition may be a water-soluble liquid agent diluted with an excipient containing water, and the liquid agent type may provide convenience to the user.
In addition, the composition of the present invention may be diluted in water by those of ordinary skill in the art. When diluted with water, the dilution amount can be arbitrarily adjusted by a person skilled in the art. For example, the composition of the present invention may be diluted in the range of 2 to 5000 times, in which case phosphoric acid or phosphate compound Is preferably used in an amount of 0.01 to 0.5% by weight and diluted in an excipient containing water. If the content is less than 0.01% by weight, the concentration of the effective ingredient may be too low to effectively isolate the gastropods. If the content exceeds 0.5% by weight, the mortality of gastropods may increase. In particular, when the concentration of phosphoric acid is high, it is very undesirable because the shell of the gastro-intestinal tract may melt and lead directly to the dead, so it is very important to maintain proper concentration. This can be understood with reference to Examples and Experimental Examples to be described later.
The gastropods refer to a herd of mollusks such as abalone, beetle, scorpion, leech, and pentagonal. Particularly, the composition of the present invention can be very usefully used for the separation of abalone.
Hereinafter, the present invention will be described in more detail by way of examples. It is to be understood that the following embodiments are for the purpose of illustration only and are not intended to limit the scope of the present invention.
Example
Identification and selection of active ingredients
Examples 1 to 4 and Comparative Examples 1 to 5 were prepared by prescribing the components as shown in Table 1 below. The units in Table 1 below are% by weight relative to the total composition.
The compositions were prepared according to each of the Examples and Comparative Examples in Duk-dong, Cheonghae, Gogun-myeon, Wando-gun, Jeollanam-do and dissolved in 400 L of each of Examples 1 to 4, and 1 kg of each of Comparative Examples 1 to 5 in 40 L of seawater. (125 x 60 cm) and the number of abalone spots separated and separated from the abalone attached to the floor below the shelter were compared with the mortality rate after 7 days of separation. The active ingredients used in the comparative examples were selected for use in conventional rollover separating agents. Usually 1 shelter and bottom have about 1,100 ~ 1,300 rolled up spoons. It is customary to check the mortality rate about 3 days after separating agent treatment in fish market. However, in this experiment, the test water before separation and the separation efficiency and the separation efficiency after separation were compared, and the mortality rate for 7 days, which is more than the period of confirmation of dead fish, was shown in Table 2 below.
As shown in Table 2, in the case of Examples 1 to 4 containing phosphoric acid as a main component, the separation efficiency of the rolled spatula greatly increased when citric acid, vitamin C, acetic acid, or oxytetracycline was used as an active ingredient Respectively. In addition, it was confirmed that mortality of overturned spoilage was improved as compared with those of conventional detergent efficacies. In particular, when acetic acid was used, the mortality was greatly increased, and it was judged that it was not preferable to use it as a separating agent for the purpose of separating overturning spots. However, the higher the concentration of phosphoric acid in the product, the higher the mortality rate of the abalone sprouts. Therefore, it was confirmed that the appropriate level of phosphoric acid content was required for the separation efficiency and mortality rate.
Separation agent design
As shown in Table 2, when phosphoric acid was used, it was confirmed that not only the separation efficiency of the rolled spore was excellent, but also the mortality rate was remarkably low, and was selected as an effective ingredient. In addition to phosphoric acid as an active ingredient, propylene glycol was added to the formulation to prevent dispersion of the product during winter season and dilution to seawater, and formulation ingredients for other formulations were included. After prescribing as shown in Table 3 below, 400 mL and 40 L of seawater were respectively dissolved and sprayed onto a rolled spatula attached to the bottom of a shelter (125 x 60 cm) and a shelter with a high-pressure atomizer, And the mortality rate after 7 days of isolation were compared. The results are shown in Table 4 below.
As shown in Table 4, it was confirmed that the use of propylene glycol was effective in lowering the mortality of the rolled spore. The content of phosphoric acid in the product is preferably 50% by weight or less, more preferably 5 to 30% by weight, based on the weight of the whole preparation, based on 100-fold dilution.
Dilution Experiment on Concentration
In order to separate the abalone, it was necessary to be over the size that can overcome the chemical stimulation of the abalone separating agent. The width of the abalone (the narrowest surface of the abalone shell) was usually 7 mm or more. In the case of the sponge attached to the bottom of the water tank, the exposure of the separating agent is relatively long due to the horizontal movement, The amount of contact is high, and the risk of our company is higher.
Table 5 and Table 6 below show the results of the experiment on the dropout rate and survival rate of the spore by phosphoric acid concentration. Table 5 is for the spoilage, and Table 6 is for the spoilage.
Phosphoric acid can be used in a relatively wide range of dilution concentrations in a 7-15 mm sponge. If the dilution concentration is low, the mortality rate is decreased but the dropout rate is lowered and the working speed is slowed down. If the dilution concentration is increased, the dropout rate is increased and the working speed is increased, but the mortality rate is increased. Seedlings seem to be preferable within the concentration range of about 0.04% to 0.35%, and in the case of sparrows, it is preferable that the concentration range is about 0.1% to 0.45%.
From the above description, it will be understood by those skilled in the art that the present invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. In this regard, the embodiments described above are illustrative in all aspects and not restrictive. The scope of the present invention should be construed as being included in the scope of the present invention without departing from the scope of the present invention as defined by the appended claims.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150127009A KR101942771B1 (en) | 2015-09-08 | 2015-09-08 | Separating composition for gastropoda |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150127009A KR101942771B1 (en) | 2015-09-08 | 2015-09-08 | Separating composition for gastropoda |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20170029874A KR20170029874A (en) | 2017-03-16 |
| KR101942771B1 true KR101942771B1 (en) | 2019-01-28 |
Family
ID=58497756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020150127009A KR101942771B1 (en) | 2015-09-08 | 2015-09-08 | Separating composition for gastropoda |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR101942771B1 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100375676B1 (en) | 2000-04-19 | 2003-03-15 | 대한민국 | A method of desquamation on matrix clung seeds sea-ear |
| JP2004043752A (en) * | 2002-07-10 | 2004-02-12 | Torai Chemical:Kk | Removing agent for adhered shell on ship's bottom and installation in the sea |
| KR101612669B1 (en) * | 2015-01-13 | 2016-04-14 | 문일 | Separating composition for gastropoda |
-
2015
- 2015-09-08 KR KR1020150127009A patent/KR101942771B1/en active IP Right Grant
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100375676B1 (en) | 2000-04-19 | 2003-03-15 | 대한민국 | A method of desquamation on matrix clung seeds sea-ear |
| JP2004043752A (en) * | 2002-07-10 | 2004-02-12 | Torai Chemical:Kk | Removing agent for adhered shell on ship's bottom and installation in the sea |
| KR101612669B1 (en) * | 2015-01-13 | 2016-04-14 | 문일 | Separating composition for gastropoda |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170029874A (en) | 2017-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69908626T2 (en) | ORAL COMBINATION OF LUFENURON AND NITENPYRAM AGAINST FLAE | |
| EP1830647A2 (en) | Method for controlling mycoses in leguminous plants | |
| DE1695269C3 (en) | 2-Dialkylamino-4-pyrimidinyl carbamates, processes for the preparation thereof and pesticides containing them | |
| CN101352172B (en) | Pesticide composition based on Thiamethoxam | |
| EP1830644A1 (en) | Fungicidal mixtures | |
| CN101352167B (en) | Pesticide composition based on nitenpyram | |
| EP2148671A1 (en) | Use of fungicides for treating fish mycoses | |
| CN104322558A (en) | Sterilization composition and applications thereof | |
| JPH0344306A (en) | Method for inhibiting sea-louse | |
| AU726556B2 (en) | A long acting injectable parasiticidal composition and the process for its preparation | |
| DE112018004491T5 (en) | Use of pyridylurea compounds with molluscicidal activity | |
| EP1435780B1 (en) | Method for controlling beetles | |
| KR101942771B1 (en) | Separating composition for gastropoda | |
| DE4017019A1 (en) | USE OF SUBSTITUTED SS-HYDROXYETHYLAMINES AS POTENTIAL INGREDIENTS OF THE EXOENZYME OF MUSHROOMS | |
| KR101612669B1 (en) | Separating composition for gastropoda | |
| DE60017465T2 (en) | COMBINATION OF FLUAZURON AND IVERMECTIN AGAINST PARASITES | |
| AU2017247267A1 (en) | Application of tenvermectin for preventing and treating parasite infection | |
| KR102050708B1 (en) | Composition for disinfection and acaricide, and method for controlling of red mite using the same | |
| US6193989B1 (en) | Long acting injectable parasiticidal composition and the process for its preparation | |
| FI119042B (en) | Solution for direct application to the skin for control of parasites on cattle and sheep | |
| CN106860442B (en) | Composition bactericide and application thereof in aquaculture | |
| EP0279290A2 (en) | Anticoccidial agent | |
| CN106922655B (en) | Bactericidal composition containing stabilizer | |
| KR102141600B1 (en) | Red mite acaricidal composition comprising calcium hydroxide | |
| CN101919401A (en) | Thiamethoxam based pesticide composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E601 | Decision to refuse application | ||
| J201 | Request for trial against refusal decision | ||
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2017101005270; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20171030 Effective date: 20181226 |
|
| S901 | Examination by remand of revocation | ||
| GRNO | Decision to grant (after opposition) | ||
| GRNT | Written decision to grant |